At my core, I’m a big picture strategist and culture transformer whose mind is on the future. Developing growth strategies, optimizing operating models, spurring innovation, and instilling a “one-company” culture and ethos to fuel enterprise maturation is my sweet spot. Case in point: I most recently spearheaded BioMarin’s first transformation office and enterprise growth strategy team that has paved the way for new capabilities, operational efficiencies, and the company’s four-year strategic plan. My ability to seamlessly drive enterprise strategy, growth, and transformation is informed by decades of experience bringing best/first-in-class therapies to market and climbing to the top of competitive marketplaces. I’ve been in the trenches – transformation, operating model evolution, corporate communications, product commercialization, sales, marketing, fund raising – across my time at the likes of BioMarin, Roche, Genentech, Biogen, and Bayer. As a result, I can quickly spot organization pain points and breakdowns as well as areas ripe for opportunity, efficiency, and disruption. Given that my career began directly impacting communities in the nonprofit world – I always gravitate towards the “why” behind everything I do. In the biopharma world, our why is so compelling. Patients are waiting for companies to bring novel treatments forward, and I always bring that “why” – the patient – into the fold to maximize teams and results. Key Differentiators: ➟ Led team to deliver first-ever future-focused redesign of BioMarin’s operating model, resulting in $63M annualized savings and significant operational efficiencies.➟ Architected Roche/Genentech’s global commercial strategy and go-to-market approach for HEMLIBRA – the largest revenue-generating bispecific antibody on market to date.➟ Deep expertise in competitive rare diseases, particularly in Hemophilia. ➟ As the youngest Executive Director in the history of the Hemophilia Association of San Diego, increased agency revenues 500% and tripled meaningful patient support programs.➟ Highly engaged in the biopharma industry and community, widely involved as a board member, volunteer, and executive sponsor.